Leadership Council
The LSI Leadership Council is a group of approximately 30 biotechnology and life sciences industry leaders, venture capitalists, media representatives, and government officials. They are linked electronically and meet in person at least once a year in Ann Arbor. Members exchange information and provide constructive discussion, advice and support for the Life Sciences Institute. The commitment of participation is two years.
Members
- Raj Alva - Managing Director, Lazard Freres
- David Canter - Senior Vice President, Global Research and Development, Pfizer, Inc.
- Michael Finney - President and CEO, Ann Arbor SPARK and the Washtenaw Development Council
- Jim Hackett - President and CEO, Steelcase, Inc.
- Bill Hall - Chairman and CEO, Procyon Technologies
- Shiraz Ladiwala - Vice President of Strategy and Business Development, Thermo Fisher Scientific
- Ernie Ludy - Founder; Former Chairman and CEO, The Medstat Group
- Greg Margolies - Head, Leveraged Finance Organization Group, Merill Lynch
- Joel Martin - Partner, Forward Ventures
- Roger Newton - President, Esperion Therapeutics and Former Senior Vice President, Pfizer Global Research and Development
- Jim Niedel - Venture Partner, Healthcare Technology, Sprout Group
- John Osborn - Senior Vice President, General Counsel and Secretary, Cephalon, Inc.
- Craig Parker (Chair) - President, DCD BioConsulting and Former Managing Director and Head of Biotechnology Equity Research, Lehman Brothers
- Dr. Joe Schwarz - Former US Representative, 7th Congressional District
- Greg Simon - President, FasterCures (The Center for Accelerating Medical Solutions)
- Michael Staebler - Partner, Pepper Hamilton LLP
- David Walt - Robinson Professor of Chemistry, Tufts University
- Deborah Widener - Former Managing Director, Pharmaceuticals/Biotech, Adams Harkness (Retired)
